Cite
HARVARD Citation
Kramar, A. et al. (n.d.). 2090 Prognostic score (REGOSCORE) for survival after Regorafenib (RE) treatment for patients (pts) with pretreated metastatic colorectal cancer (mCRC). European journal of cancer. pp. S358-. [Online].